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It is amazing what we can do with current tools of molecular biology. I often tell students 
we can answer questions today that we couldn’t even phrase 30 years ago. For example, 
we can query whole genomes in a variety of ways, from sequencing to gene expression to 
chromatin status. In addition, for the last dozen years or so we have had the capability to 
modify genomes with great range, subtlety and specificity, and with striking efficiency. Part 
of this meeting is dedicated to describing the tools for making such modifications, and I 
will do my part. I will also offer a few thoughts about the applications of this technology 
in ways that have great potential for improving the human condition.
Zinc Fingers
First, a little history. As implied by their “nuclease” designations, the genome-engineering 
tools act by making breaks in DNA. Many years of research on many different organisms 
and in many laboratories led to an understanding by the mid-1990s that double-strand 
breaks are repaired by cellular mechanisms that rely on homologous recombination or 
error-prone end joining. This suggested that the very low frequency of “classical” gene 
targeting could be improved by making targeted double-strand breaks. Meanwhile, Chan-
drasegaran and colleagues discovered that the recognition and cleavage activities of the 
Type IIS restriction endonuclease, FokI, could be physically separated (Kim et al., 1996). 
They replaced the natural recognition domain with alternatives from other sources and 
showed that cleavage was redirected to new sites. When they linked the cleavage domain 
to a set of zinc fingers, they opened the door to designing reagents that would be directed 
to completely novel targets. Zinc fingers were identified in natural eukaryotic sequence-
specific transcription factors and were known to bind DNA in very modular fashion—one 
finger per three base pairs—and fingers had already been identified for a number of dif-
ferent triplets. Thus, in addition to basic advances in DNA manipulation, three specific 
research threads led to the production of the first zinc-finger nucleases (ZFNs).
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In a nutshell, early work with ZFNs showed that it takes two such constructs to cut 
DNA efficiently, since the cleavage domain must dimerize, and the dimer interface is 
quite weak. An optimal linker between the binding and cleavage domains was identi-
fied. Despite the fact that the nuclease domain came from a bacterium, ZFNs effectively 
cleaved targets that were assembled into chromatin.
The next major step was the demonstration of ZFN activity in whole cells and organ-
isms. The first such experiments were done with Drosophila melanogaster, demonstrating 
both targeted mutagenesis by simple cleavage and reliance on inaccurate repair and 
 homologous gene replacement when an appropriate donor DNA was supplied. Additional 
work showed efficacy in cultured human cells, in plants and in nematodes. By now, ZFNs 
and other nucleases have been used successfully to modify the genomes of more than 50 
distinct organisms.
A drawback to the use of ZFNs was the difficulty of deriving reliable designs for new 
targets. Assembling new combinations of fingers from existing libraries was successful in 
some cases, but not in others. Methods for selecting novel combinations for individual new 
targets from mutagenized pools helped, but were not widely adopted for various reasons. 
Very reliable constructs were and are available commercially, but at prices inaccessible to 
some. Nonetheless, ZFNs have been used widely.
TALENs
The discovery of a simpler DNA-recognition code in transcription activator-like effectors 
(TALEs) in Xanthomonas bacteria led to a new platform for targeted cleavage. In these 
proteins, each module binds a single base pair, and individual modules reliably recognize 
each of the four types of base pair. Thus, new recognition domains could be assembled 
simply by reading the target DNA sequence and inserting the appropriate TALE subunit. 
Linkage to the FokI cleavage domain created TALE nucleases (TALENs) that, like ZFNs, 
needed to be provided in pairs to ensure cleavage. It is perhaps fortunate that, again like 
zinc fingers, the TALE modules naturally bind DNA in a chromatin context, in this case 
targets in plant-host chromosomes. TALENs were rapidly adopted in preference to ZFNs, 
particularly in research labs, for the simplicity of their design, for the higher rate of success 
of new designs, and the apparent sequence specificity of the ultimate reagents.
CRISPRs
The latest additions to the tool kit are the CRISPR/Cas RNA-guided nucleases that I 
like to simply call CRISPRs. In this case, recognition is mediated by a guide RNA, using 
 Watson-Crick base pairing, making designs for new targets even simpler than for TALENs. 
In addition, a single protein, Cas9, is required, and it doesn’t need to be modified when the 
target is changed. These features have led to very rapid adoption of CRISPR nucleases.
Common Characteristic
An important characteristic common to these three platforms is that DNA recognition 
and cleavage are mediated by functionally separable domains. This means that each can 
be manipulated independent of the other, which is, of course, critical for attacking new 
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targets by changing binding specificity. The nuclease domains have also been manipulated 
in various fashions, notably to produce single- rather than double-strand breaks at the 
target.
Ultimately, these targetable nucleases make breaks only at the desired DNA targets. 
Everything that happens afterward depends on cellular DNA-repair activities. This means 
that the outcomes of a nuclease-mediated targeting event may be different in different 
organisms or cell types, depending on the status of those repair activities. In addition, the 
ways in which the nucleases—and donor DNA, when homologous repair is sought—are 
delivered will depend on what is appropriate in any application.
Model Fruit Fly
We have investigated a number of these repair parameters using Drosophila as the model 
organism. We asked, What gene products participate in nuclease-mediated targeting, and what 
are the consequences of disabling each of them? Not surprisingly, we found that the Rad51 
and Rad54 homologues were required for most (but not quite all) of homologous repairs. 
More importantly, in the absence of DNA ligase IV (Lig4), a dedicated component of 
nonhomologous end joining (NHEJ), the majority of repairs proceeded by homologous 
recombination (HR). In many experimental situations, HR is the desired pathway. It is 
not possible to propagate Lig4 mutants of quite a number of organisms, so alternative 
means of disabling the enzyme, or other NHEJ activities, are being sought.
Another important question regarding homologous repair is, How much homology is 
needed to support efficient sequence replacement?
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